HIV Antibodies: Further Questions and a Plea for Clarification

References

• Gallo R. C., Sarin P. S., Kramarsky B., Salahuddin Z., Markham P., Popovic M. First isolation of HTLV-III. Nature 1986; 321: 1191. Gallo R. C., Sarin P. S., Kramarsky B., Salahuddin Z., Markham P., Popovic M. First isolation of HTLV-III. Nature 1986; 321: 119
   PubMedGoogle Scholar
• Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224: 497, 5002. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224: 497, 500
   PubMed Web of Science ®Google Scholar
• Gallo R. C., Wong-Staal F., Reitz M., Gallagher R. E., Miller N., Gillepsie D. H. Some evidence for infectious type-C virus in humans. Animal Virology, D. Baltimore, A. S. Huang, C. F. Fox. Academic Press, New York 1976; 38–053. Gallo R. C., Wong-Staal F., Reitz M., Gallagher R. E., Miller N., Gillepsie D. H. Some evidence for infectious type-C virus in humans. Animal Virology, D. Baltimore, A. S. Huang, C. F. Fox. Academic Press, New York 1976; 38–05
   Google Scholar
• Gallagher R. E., Gallo R. C. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Science 1975; 187: 356, 3534. Gallagher R. E., Gallo R. C. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Science 1975; 187: 356, 353
   Google Scholar
• Teich N. M., Weiss R. A., Salahuddin S. Z., Gallagher R. E., Gillepsie D. H., Gallo R. C. Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells. Nature 1975; 256: 551, 5555. Teich N. M., Weiss R. A., Salahuddin S. Z., Gallagher R. E., Gillepsie D. H., Gallo R. C. Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells. Nature 1975; 256: 551, 555
   PubMed Web of Science ®Google Scholar
• Snyder H. W., Fleissner E. Specificity of human antibodies to oncovirus glycoproteins: Recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl Acad. Sci. USA 1980; 77: 1622, 16266. Snyder H. W., Fleissner E. Specificity of human antibodies to oncovirus glycoproteins: Recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl Acad. Sci. USA 1980; 77: 1622, 1626
   PubMed Web of Science ®Google Scholar
• Barbacid M., Bolognesi D., Aaronson S. A. Humans have antibodies capable of recognizing oncoviral glycoproteins: Demonstration that these antibodics are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc. Natl Acad. Sci. USA 1980; 77: 1617, 16217. Barbacid M., Bolognesi D., Aaronson S. A. Humans have antibodies capable of recognizing oncoviral glycoproteins: Demonstration that these antibodics are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc. Natl Acad. Sci. USA 1980; 77: 1617, 1621
   PubMed Web of Science ®Google Scholar
• Kalyanaraman V. S., Sarngadharan M. G., Bunn P. A., Gallo R. C. Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature 1981; 294: 271, 2738. Kalyanaraman V. S., Sarngadharan M. G., Bunn P. A., Gallo R. C. Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus. Nature 1981; 294: 271, 273
   PubMed Web of Science ®Google Scholar
• Gelderblom H. R., Özel M., Hausmann E. H. S., Winkel T., Pauli G., Koch M. A. Fine structure of human immunodeficiency virus (HIV), immunolocalization of structural proteins and virus-cell relation. Micron Microscopica 1988; 19: 41, 609. Gelderblom H. R., Özel M., Hausmann E. H. S., Winkel T., Pauli G., Koch M. A. Fine structure of human immunodeficiency virus (HIV), immunolocalization of structural proteins and virus-cell relation. Micron Microscopica 1988; 19: 41, 60
   Web of Science ®Google Scholar
• Papadopulos-Eleopulos E., Turner V. F., Papdimitriou J. M. Is a positive Western Blot proof of HIV infection?. Bio/Technology 1993; 11: 696–707, (June)10. Papadopulos-Eleopulos E., Turner V. F., Papdimitriou J. M. Is a positive Western Blot proof of HIV infection?. Bio/Technology 1993; 11: 696–707, (June)
   PubMedGoogle Scholar
• Mortimer P., Codd A., Connolly J. Towards error free HIV diagnosis: notes on laboratory practice. Pub. Health Lab. Service Micrbiol. Digest 1992; 9: 61, 6411. Mortimer P., Codd A., Connolly J. Towards error free HIV diagnosis: notes on laboratory practice. Pub. Health Lab. Service Micrbiol. Digest 1992; 9: 61, 64
   Google Scholar
• Muller W. E. G., Schroder H. C., Reuter P., Maidhof A., Uhlenbruck G., Winkler I. Polyclonal antibodies to mannan from yeast also recognize the carbohydrate structure of gp 120 of the AIDS virus: an approach to raise neutralizing antibodies to HIV-1 infcction in vitro. AIDS 1990; 4: 159, 16212. Muller W. E. G., Schroder H. C., Reuter P., Maidhof A., Uhlenbruck G., Winkler I. Polyclonal antibodies to mannan from yeast also recognize the carbohydrate structure of gp 120 of the AIDS virus: an approach to raise neutralizing antibodies to HIV-1 infcction in vitro. AIDS 1990; 4: 159, 162
   PubMed Web of Science ®Google Scholar
• Mullcr W. E. G., Bachmann M., Weiler B. E. Antibodies against defined carbohydrate structures of Candido dhicans protect H9 cells against infection with human immunodeficiency virus-] in vitro. J. Acquir. Immun. Defic. Syndr. 1991; 4: 694, 70313. Mullcr W. E. G., Bachmann M., Weiler B. E. Antibodies against defined carbohydrate structures of Candido dhicans protect H9 cells against infection with human immunodeficiency virus-] in vitro. J. Acquir. Immun. Defic. Syndr. 1991; 4: 694, 703
   PubMed Web of Science ®Google Scholar
• Tomiyama T., Lake D., Masuho Y., Hersh E. M. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem. Biophys. Res. Commun. 1991; 177: 279, 28514. Tomiyama T., Lake D., Masuho Y., Hersh E. M. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem. Biophys. Res. Commun. 1991; 177: 279, 285
   PubMed Web of Science ®Google Scholar
• Kashala O., Marlink R., Ilunga M. Infection with human immunodeficiency virus type 1 (HIV-I) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-I cross-reactivity and antibodies to lipo-arabinoniannan. J. Infect. Dis. 1994; 169: 296, 30415. Kashala O., Marlink R., Ilunga M. Infection with human immunodeficiency virus type 1 (HIV-I) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-I cross-reactivity and antibodies to lipo-arabinoniannan. J. Infect. Dis. 1994; 169: 296, 304
   PubMed Web of Science ®Google Scholar
• Ezckowitz R. A., Williams D. J., Koziel H. Uptake of Pneumocystis carinni mediated by the macrophage mannose receptor. Nature 1991; 351: 155, 15816. Ezckowitz R. A., Williams D. J., Koziel H. Uptake of Pneumocystis carinni mediated by the macrophage mannose receptor. Nature 1991; 351: 155, 158
   PubMed Web of Science ®Google Scholar
• Hoffman O. A., Standing J. E., Limper A. H. Pneumocystis carinni stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 1993; 150: 3932, 394017. Hoffman O. A., Standing J. E., Limper A. H. Pneumocystis carinni stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 1993; 150: 3932, 3940
   PubMed Web of Science ®Google Scholar
• O'Riordan D. M., Standing J. E., Limper A. H. Pneumocystis carinni glycoprotcin A binds macrophage mannose receptors. Infect-Immun. 1995; 63: 779, 78418. O'Riordan D. M., Standing J. E., Limper A. H. Pneumocystis carinni glycoprotcin A binds macrophage mannose receptors. Infect-Immun. 1995; 63: 779, 784
   PubMed Web of Science ®Google Scholar
• Matthcws R., Smith D., Midglcy J. Candida and AIDS: Evidence for protective antibody. Lancet 1988; ii: 263, 26619. Matthcws R., Smith D., Midglcy J. Candida and AIDS: Evidence for protective antibody. Lancet 1988; ii: 263, 266
   Google Scholar
• Caceres C. F., van Griensven G. J. P. Male homosexual transmission of HIV-I. AIDS 1994; 8: 105l–106120. Caceres C. F., van Griensven G. J. P. Male homosexual transmission of HIV-I. AIDS 1994; 8: 105l–1061
   Google Scholar
• Mann T., Lutwnk-Mann C. Male Reproductive Function and Semen. Springer-Verlag, New York 198121. Mann T., Lutwnk-Mann C. Male Reproductive Function and Semen. Springer-Verlag, New York 1981
   Google Scholar
• Fraziano M., Montesano C., Lombardi V. R. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. AIDS Res. Hum. Retroviruses. 1996; 12: 491, 49622. Fraziano M., Montesano C., Lombardi V. R. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. AIDS Res. Hum. Retroviruses. 1996; 12: 491, 496
   PubMed Web of Science ®Google Scholar
• Kion T. A., Hoffman G. W. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmuc mice. Science 1991; 253: 1138, 114023. Kion T. A., Hoffman G. W. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmuc mice. Science 1991; 253: 1138, 1140
   PubMed Web of Science ®Google Scholar
• Hu D. J., Fleming P. L., Castro K. G. How important is racelethnicity as an indicator of risk for specific AIDS-defining conditions?. J. Acquir. Immun. Def. Syndr. Hum. Reirovirol 1995; 10: 374, 38024. Hu D. J., Fleming P. L., Castro K. G. How important is racelethnicity as an indicator of risk for specific AIDS-defining conditions?. J. Acquir. Immun. Def. Syndr. Hum. Reirovirol 1995; 10: 374, 380
   PubMed Web of Science ®Google Scholar
• Calahrese L. H. The rheumatic manifestations of infection with the human immunodcficicncy virus. Semin. Arthritis Rheum. 1989; 18: 225, 23925. Calahrese L. H. The rheumatic manifestations of infection with the human immunodcficicncy virus. Semin. Arthritis Rheum. 1989; 18: 225, 239
   PubMed Web of Science ®Google Scholar
• Nakamara M., Burastero S. E., Ueki Y., Larrie J. W., Notkj A. L., Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus: Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J. Immunol. 1988; 141: 4165, 417226. Nakamara M., Burastero S. E., Ueki Y., Larrie J. W., Notkj A. L., Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus: Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus. J. Immunol. 1988; 141: 4165, 4172
   PubMed Web of Science ®Google Scholar
• Sinoussi F., Mendiola L., Chermann J. C. Purification and partial differentiation of the particlcs of niurine sarcoma virus (M. MSV) according to their sedimentation rates in sucrose density gradients. Spectra 1973; 4: 237, 24327. Sinoussi F., Mendiola L., Chermann J. C. Purification and partial differentiation of the particlcs of niurine sarcoma virus (M. MSV) according to their sedimentation rates in sucrose density gradients. Spectra 1973; 4: 237, 243
   Google Scholar
• Toplin I. Tumor virus purification using zonal rotors. Specrra 1973, No. 4: 225–23528. Toplin I. Tumor virus purification using zonal rotors. Specrra 1973, No. 4: 225–235
   Google Scholar